Entry

D06709            Crude     Drug

Name

Lycium fruit (JP18)

Component

Betaine [CPD:C00719], Vitamins, Zeaxanthin [CPD:C06098], Physalien [CPD:C08609], beta-Sitosterol [CPD:C01753], Cinnamic acid [CPD:C10438], Kukoamine A [CPD:C17615], Kukoamine B [CPD:C17616], Kukoamine C [CPD:C17617], Kukoamine D [CPD:C17618]

Source

Lycium chinense [TAX:112883], Lycium barbarum [TAX:112863]

Remark

Therapeutic category:

5100

Product:

D06709<JP>

Efficacy

Analeptic

Comment

Solanaceae (nightshade family) Lycium mature fruit
Major component: Betaine [CPD:C00719]

Brite

Therapeutic category of drugs in Japan [BR:br08301]
5  Crude drugs and Chinese medicine formulations
  51  Crude drugs
   510  Crude drugs
    5100  Crude drugs
     D06709  Lycium fruit (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
  Crude drugs
   Lycium fruit
    D06709  Lycium fruit (JP18)
Traditional Chinese Medicine in Japan [BR:br08304]
Crude drugs
  Drugs for Qi
   Drugs for replenishing Qi
    D06709  Lycium fruit
Crude drugs [BR:br08305]
Dicot plants: asterids
  Solanaceae (nightshade family)
   D06709  Lycium fruit
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
  D06709  Lycium fruit

Other DBs

PubChem:

47208360